Published July 25, 2023 | Version v1
Journal article Open

Secretory Proteomic Responses of Endometrial Epithelial Cells to Trophoblast-Derived Extracellular Vesicles

  • 1. ROR icon Estonian University of Life Sciences
  • 2. ROR icon University of Peradeniya
  • 3. ROR icon University of Tartu
  • 4. ROR icon University of Sheffield

Description

Synchronized crosstalk between the embryo and endometrium during the periconception period is integral to pregnancy establishment. Increasing evidence suggests that the exchange of extracellular vesicles (EVs) of both embryonic and endometrial origin is a critical component of embryo–maternal communication during peri-implantation. Here, we investigated whether embryonic signals in the form of EVs can modulate the endometrial epithelial cell secretome. Receptive endometrial analog RL95-2 cells were supplemented with trophoblast analog JAr cell-derived EVs, and the secretory protein changes occurring in the RL95-2 cells were analyzed using mass spectrometry. EVs of non-trophoblastic origin (HEK 293 cells) were used as the control EV source to supplement endometrial cells. Trophoblast cell-derived EVs enriched endometrial epithelial cell secretions with proteins that support embryo development, attachment, or implantation, whereas control EVs were unable to induce the same effect. The present study suggests that embryonic signals in the form of EVs may prime receptive endometrial epithelial cells to enrich their secretory proteome with critical proteomic molecules with functional importance for periconception milieu formation.

Files

ijms-24-11924-v2.pdf

Files (1.2 MB)

Name Size Download all
md5:c1b808aa2b63a1fb1702c80fcaff9b1e
1.2 MB Preview Download

Additional details

Funding

COMBIVET – Setting up the ERA Chair of Comparative Medicine in the Institute of Veterinary Medicine and Animal Sciences of the Estonian University of Life Sciences 857418
European Commission
OH-Boost – Boosting the One Health Research Excellence and Management Capacity of the Estonian University of Life Sciences 101079349
European Commission

Dates

Submitted
2023-06-21
Accepted
2023-07-18